Android app on Google Play

Cornerstone Therapeutics, Inc. (CRTX) Misses Q3 EPS by 13c

November 8, 2012 7:18 AM EST Send to a Friend
Cornerstone Therapeutics, Inc. (NASDAQ: CRTX) reported Q3 EPS of $0.19, $0.13 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $37.5 million versus the consensus estimate of $32 million.

For earnings history and earnings-related data on Cornerstone Therapeutics, Inc. (CRTX) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment